TOFO Insulin Combination Trial

NCT02201004 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: TOFOGLIFLOZIN CSG452
DRUG: insulin
DRUG: placebo

Sponsor

Sanofi

Collaborators

[object Object]